Ayal Zylberman - Intelicanna Deputy CEO, Director
| TEFN Stock | 62.00 0.30 0.49% |
CEO
Mr. Ayal Zylberman was appointed Deputy Chief Executive Officer and Director at Tefen Industrial Engineering Management and Systems Analysis Ltd. and will no longer serve as Chairman of the Board effective July 1, 2017. He held the role of Chairman of the Board at the Company from May 28, 2015 and as Director at the Company from May 12, 2015. His work experience includes the role of President at Qualitest Company Ltd. He holds a Bachelors degree in Accounting and Economics and a Masters degree in Economics, both from Tel Aviv University. since 2017.
| Age | 42 |
| Tenure | 7 years |
| Phone | 972 3 977 5151 |
| Web | www.tefen.com |
Similar Executives
| Found 6 records | CEO Age | ||
| Limor Avidor | Mivtach Shamir | 56 | |
| Eliahu Cohen | EN Shoham Business | 53 | |
| Eran Horovitz | EN Shoham Business | 33 | |
| Zvika Almog | Telsys | 56 | |
| Ohad Yaniv | Telsys | 42 | |
| Meir Shamir | Mivtach Shamir | 72 | |
Intelicanna Leadership Team
Elected by the shareholders, the Intelicanna's board of directors comprises two types of representatives: Intelicanna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelicanna. The board's role is to monitor Intelicanna's management team and ensure that shareholders' interests are well served. Intelicanna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelicanna's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mally Parnes, CEO of the Company’s Subsidiary | ||
| Avraham Sadan, Independent Director | ||
| Erez Tova, CFO and Partner | ||
| Boaz Toshav, Independent Director | ||
| Moran Markovitz, Vice President - Finance | ||
| Ori Weiss, Chairman of the Board | ||
| Mor Balfour, Chairman of the Board | ||
| Elad Gazit, External Director | ||
| Naor Dribin, Vice President - Finance | ||
| Eliezer Pelleg, Executive Vice President | ||
| Yael NevoHirschenbein, Independent Director | ||
| Ayal Zylberman, Deputy CEO, Director | ||
| Doron Rozenblum, Internal Auditor | ||
| Saul Kaye, Director | ||
| Aharon Lichtenstein, CEO | ||
| Yona Levy, Director | ||
| Sharon Glazer, Director | ||
| Itzhak Malach, External Director | ||
| Zehavit ZivNer, External Director | ||
| Itay Rosenfeld, Director | ||
| Eyal Zilberman, Chairman of the Board | ||
| Nadia Whittley, Managing Director of Tefen Europe |
Intelicanna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intelicanna a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | (327.15) X | |||
| Revenue | 40.44 M | |||
| EBITDA | 2.29 M | |||
| Net Income | (24.63 M) | |||
| Cash And Equivalents | 1.04 M | |||
| Cash Per Share | 0.11 X | |||
| Total Debt | 1.84 M | |||
| Debt To Equity | 734.90 % | |||
| Current Ratio | 0.29 X | |||
| Book Value Per Share | (1.83) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Intelicanna in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Intelicanna's short interest history, or implied volatility extrapolated from Intelicanna options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Intelicanna. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Intelicanna Stock analysis
When running Intelicanna's price analysis, check to measure Intelicanna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelicanna is operating at the current time. Most of Intelicanna's value examination focuses on studying past and present price action to predict the probability of Intelicanna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelicanna's price. Additionally, you may evaluate how the addition of Intelicanna to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |